Sirolimus for moderate-to-severe facial skin sarcoidosis
Treatments studied
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This trial studies whether sirolimus (an immune-influencing medicine) can improve moderate-to-severe sarcoidosis affecting the face. It may help if you’ve tried standard sarcoidosis treatments before but they didn’t work well enough or stopped working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 74 years old and can give informed consent
- You have confirmed sarcoidosis in facial skin (face lesions confirmed by biopsy)
- Your facial sarcoidosis is moderate-to-severe based on doctor scoring and overall assessment
- You must have health coverage and be willing/able to follow study instructions reliably
- You are not pregnant or breastfeeding, and you can use effective birth control during treatment and for 12 weeks after stopping (if you could become pregnant)
- You cannot have certain liver problems, certain allergies (including peanut/soy), uncontrolled high blood pressure, or active infections (including tuberculosis)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an oral drug called brepocitinib to see if it can help people with skin sarcoidosis and reduce skin symptoms. It aims to find a better treatment option for this condition.
This trial studies a treatment approach for people with active cardiac sarcoidosis, confirmed by specific heart rhythm/heart function problems and a PET scan. It may help by targeting the active inflammation driving heart conduction problems, rhythm events, or weak heart pumping.
This Phase 2 trial tests sirolimus (a medicine that affects the immune system) to reduce symptoms and disease activity in adults with active systemic lupus erythematosus (SLE). You may be a good fit if your lupus is currently active despite stable standard treatments.
This trial studies whether hydroxychloroquine can control extrapulmonary sarcoidosis (sarcoidosis outside the lungs) using less steroid treatment. It may help people who need systemic therapy for problems such as eyes, skin, bones, joints, nerves, ENT areas, or high calcium levels from sarcoidosis.
This trial tests if rilonacept can help people with cardiac sarcoidosis, a condition where inflammation affects the heart. You may join if you have active inflammation on a PET scan despite standard treatments.
This trial tests sirolimus to treat idiopathic (unknown-cause) retroperitoneal fibrosis, a condition where scar tissue forms in the belly behind the kidneys. You may be considered if imaging and blood tests suggest active inflammation, and if you’re able to safely take the study medicine and return for follow-up.
Hear when a new Sarcoidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.